Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $83.3000 (-1.36%) ($80.4000 - $85.9200) on Thu. Oct. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 25 | Latest Price | $83.3000(-1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.31% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $70.81(-14.99%) | Inflection Point | Yes | Resistance Level | $93.41 | 5 Day Moving Average | $84.8(-1.77%) | 10 Day Moving Average | $86.61(-3.82%) | 20 Day Moving Average | $93.41(-10.82%) | To recent high | -34.3% | To recent low | 3.7% | Market Cap | $1.339b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |